Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Ferrandi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Hypertension|April 13, 2004
Different effects of marinobufagenin and endogenous ouabainPaolo Manunta, Mara Ferrandi
Hypertension (Dallas, Tex. : 1979)|February 8, 2006
Cardiac glycosides and cardiomyopathyPaolo Manunta, Mara Ferrandi
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 10, 2006
Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertensionPatrizia Ferrari, Mara Ferrandi, Giovanni Valentini, et al.
Pharmacogenomics|May 1, 2007
Adducin polymorphisms and the treatment of hypertensionPaolo Manunta, Lorena Citterio, Chiara Lanzani, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|March 15, 2006
A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducinPaolo Manunta, Mara Ferrandi, Elisabetta Messaggio, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complicationsMara Ferrandi, Paolo Manunta, Patrizia Ferrari, et al.
Discovery Medicine|September 1, 2011
Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac outputMihai Gheorghiade, Andrew P Ambrosy, Mara Ferrandi, et al.
Journal of Hypertension|December 4, 2008
Endogenous ouabain in cardiovascular function and diseasePaolo Manunta, Mara Ferrandi, Giuseppe Bianchi, et al.
Medical Hypotheses|November 14, 2006
Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approachPatrizia Ferrari, Mara Ferrandi, Giovanni Valentini, et al.
Current Hypertension Reports|February 26, 2016
Personalized Therapy of Hypertension: the Past and the FuturePaolo Manunta, Mara Ferrandi, Daniele Cusi, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Hypertension|April 13, 2004
Different effects of marinobufagenin and endogenous ouabainPaolo Manunta, Mara Ferrandi
Hypertension (Dallas, Tex. : 1979)|February 8, 2006
Cardiac glycosides and cardiomyopathyPaolo Manunta, Mara Ferrandi
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 10, 2006
Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertensionPatrizia Ferrari, Mara Ferrandi, Giovanni Valentini, et al.
Pharmacogenomics|May 1, 2007
Adducin polymorphisms and the treatment of hypertensionPaolo Manunta, Lorena Citterio, Chiara Lanzani, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|March 15, 2006
A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducinPaolo Manunta, Mara Ferrandi, Elisabetta Messaggio, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complicationsMara Ferrandi, Paolo Manunta, Patrizia Ferrari, et al.
Discovery Medicine|September 1, 2011
Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac outputMihai Gheorghiade, Andrew P Ambrosy, Mara Ferrandi, et al.
Journal of Hypertension|December 4, 2008
Endogenous ouabain in cardiovascular function and diseasePaolo Manunta, Mara Ferrandi, Giuseppe Bianchi, et al.
Medical Hypotheses|November 14, 2006
Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approachPatrizia Ferrari, Mara Ferrandi, Giovanni Valentini, et al.
Current Hypertension Reports|February 26, 2016
Personalized Therapy of Hypertension: the Past and the FuturePaolo Manunta, Mara Ferrandi, Daniele Cusi, et al.
Pageof 4